Transforming growth factor-β (TGF-β) is a multifunctional cytokine that play critical roles in melanoma progression. Although the impact of TGF-β signaling on melanoma progression has been well characterized, little is known about the molecular mechanisms that control TGF-β production in melanoma cells. In this study, we describe a novel role for Melanocortin Receptor 1 (MC1R) in the regulation of TGF-β production. MC1R is a cell surface endocytic receptor expressed in melanoma cells and serves as a receptor for α-Melanocyte Stimulating Hormone (α-MSH). The activation of MC1R with α-MSH resulted in increased levels of TGF-β, which was mediated by ERK1/2 and p38 signaling pathways. Furthermore, Microphthalmia Transcription Factor (MITF), the master regulator of melanocytes, was found to act downstream of MC1R to regulate TGF-β production. Targeting of MC1R-MITF axis was effective to decrease TGF-β production, and resulted in delayed tumor growth of B16 melanoma in vivo. Collectively, these results give new insight into the molecular mechanisms that control TGF-β production in melanoma cells.
Introduction
Malignant melanoma is considered as one of the most aggressive types of cancer, which show high resistance to conventional chemotherapeutic and immunotherapeutic treatment [1] [2] [3] [4] . Melanomas arise as a result of malignant transformation of melanocytes, and are associated with increased production of several growth factors and cytokines that play critical roles in tumor progression. In particular, melanomas produce increasing amounts of the transforming growth factor-β1 (TGF-β1), which is correlated with
Original Article Mechanism of TGF-β1 production in Melanoma cells disease progression. TGF-β1 is a multifunctional cytokine involved in the regulation of many biological functions of the cell including proliferation, differentiation and survival 5) .
In melanoma, TGF-β1 promotes tumor progression via autocrine effects on melanoma cell motility and invasiveness, in addition to paracrine effects including modulation of tumor stroma and extracellular matrix, enhancing angiogenesis and inhibition of immune surveillance [6] [7] [8] [9] . For these reasons, TGF-β1 has attracted much attention as a potent therapeutic target of melanoma 9) . Although the impact of TGF-β1
signaling pathway on melanoma progression has been well defined, the molecular mechanisms that underlie the enhanced TGF-β1 production in melanoma cells still poorly understood. Thus, a comprehensive analysis to clarify such mechanisms may help to identify new suitable therapeutic strategies.
Melanocortin 1 receptor (MC1R) is a cell surface endocytic
receptor expressed on melanocytes in mouse and human 10) .
MC1R can bind to adrenocorticotropic hormone (ACTH)
and α-Melanocyte Stimulating Hormone (α-MSH) [11] [12] [13] .
The activation of MC1R signaling in melanocytes induces
tyrosinase expression, resulting in enhanced synthesis of melanin 14) . Thus, MC1R is considered as a key factor that plays important roles in the melanocyte transformation process in pathological conditions such as ultraviolet radiation 14) . In melanoma, MC1R is overexpressed on the cell surface of the majority of human melanomas, and correlated with melanoma initiation, progression and metastasis 15) .
From these backgrounds, we hypothesized that since MC1R plays important roles in melanoma progression, it may also play a role in the regulation of TGF-β1 production in melanoma cells. In this study, we have evaluated this hypothesis, and found that α-MSH-mediated activation of MC1R pathway resulted in enhanced production of TGF-β1 in B16 melanoma cells. Importantly, this effect was mediated by MITF, the major regulator of melanoma cells, and the targeting of α-MSH-MC1R-MITF pathway resulted in decreased production of TGF-β1 in vitro , and delayed tumor growth in vivo. Together, our results provide new insight into the molecular mechanisms of TGF-β1 production in melanoma cells. for 1 hour before α-MSH stimulation.
Materials and methods

1)Cell culture and reagents
B16
2)RT-PCR, real time qRT-PCR and genomic PCR
Total RNA was purified from cells using RNeasy Plus Mini Kit (QIAGEN) according to the manufacturer's instruction, and used for cDNA synthesis (SuperScript III, Invitrogen).
Genomic DNA was prepared by PureLink genomic DNA mini kit (Life Technologies). cDNA and genomic DNA products were then used to amplify the target sequences using AmpliTaq Gold ® 360 Master Mix. The obtained PCR products were separated by electrophoresis in an agarose gel and visualized by GelRed (Biotium) nucleic acid gel staining and UV illumination. Quantitative RT-PCR analysis was performed to measure levels of Tgfb1 or Mc1r mRNA as normalized to the internal control Hprt , and human MC1R or TGFβ1 mRNA as normalized to the internal control β-actin using POWER SYBR ® Green (Invitrogen).
Sequences of primers are listed in Table 1 .
3)NBL-7 proliferation inhibition assay
To determine the latency and bioactivity of Tgfb1, 3x10 
4)Lentiviral shRNA-mediated knockdown of Mc1r and Mitf
Knockdown of Mc1r and Mitf was performed using shorthairpin RNAs (shRNAs). The target sequences used for knockdown were identified from the RNAi Consortium (TRC) sequence database, as listed in Reverse AGCAGTACATGGGTGAGTGC hTGF-β1
Forward CCCAGCATCTGCAAAGCTC 101 bp hTGF-β1
Reverse GTCAATGTACAGCTGCCGCA β-actin
Anti-sense CTAGAAAAGCAAATACGTTACCCGTCTCTGTGACAG GAAGCAGAGACAGGTAACATATTTACGGG
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CS-RfA-EG lentiviral vector (provided by Dr. H. Miyoshi)
were employed in a recombination reaction using Gateway system (Invitrogen) according to the manufacturer's protocol.
The generated lentiviral shRNA vectors were then cotransfected along with a packaging set of pCAG-HIV-
gp, VSV-G and pCMV-VSV-G-RSV-ReV plasmids into
Lenti-X 293T cells using Polyethyleneimine "MAX" (PEImax, Polysciences, Inc.). 12 hours after transfection, medium was changed into fresh DMEM containing 1μM
Forskolin, and cells were incubated for additional 24
hours. Subsequently, the supernatants containing the viral particles were collected, filtered through 0.45 μm filters. B16 Fisher Scientific) or ECL prime (GE health care). Signals were detected using ImageQuant LAS 4000 mini (GE Healthcare Life Sciences) and quantified using Image J.
6)Reporter Gene Assay
The coding region of Mitf-M was amplified by PCR from cDNA template using KOD-Plus-Neo Kit (TOYOBO CO., 
7)Animal experiment
Six-to eight-weeks old C57BL/6 female mice were purchased from SLC Japan, Inc. (Tokyo, Japan). Mice (N=5)
were inoculated subcutaneously into the back with 3X10 Committee of Hokkaido University.
8)Statistical Analysis
Statistical analysis was performed using one-way analysis of variance and post-hoc analysis was done by unpaired t Original Article Mechanism of TGF-β1 production in Melanoma cells B16 melanoma cells (Fig. 1A) . Next, we examined whether MC1R-mediated signaling contribute to Tgfb1 production.
To do so, we evaluated the expression level of Tgfb1 at mRNA and protein levels ( Fig. 1B and 1C) . To further confirm the existence of active Tgfb1 in the supernatants of B16 cells, we performed proliferation inhibition assay using mink lung epithelial cells (NBL-7). The proliferation of NBL-7 cells is inhibited in response to TGF-β [17] [18] [19] , thus
we next compared the proliferation of NBL-7 cells when cultured with supernatants collected from non-stimulated or α-MSH-stimulated B16 cell culture (Fig. 1D ). As expected, we found that the proliferation of NBL-7 cells was inhibited when cultured in the presence of α-MSH-stimulated-B16 cell supernatant, which indicates the enrichment of B16 cells culture with Tgfb1 following α-MSH stimulation (Fig.   1E ). Furthermore, we found that a neutralizing antibody for TGF-β was effective to abolish the effects of B16 supernatants as indicated by recovery in NBL-7 proliferation (Fig. 1F) , suggesting that Tgfb1 is the responsible factor for suppressing NBL-7 proliferation in this assay. Together, Data are shown as representative of 2 independent experiments. *p<0.05.
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these results suggest that α-MSH-mediated signaling contribute to Tgf-β1 production in B16 cells.
2)Mc1r Knockdown decreases Tgfb1 production in α-MSH-stimulated B16 melanoma cells
As suggested by the above data, α-MSH stimulation 
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α-MSH-MC1R signaling axis to regulate Tgfb1 production in B16 melanoma cells.
3)Mitf is the responsible factor for enhancing Tgf-β1 production in α-MSH-stimulated B16 cells
Next, we aimed to identify signaling pathways that act (Fig. 3A) .
On the other hand, the inhibition of NBL-7 cells proliferation was not observed when B16 cells were pretreated with inhibitors of MEK or p38 before α-MSH stimulation (Fig.   3A) . Thus, we concluded that Erk1/2 and p38 pathways are important for MC1R-mediated signaling, since inhibitors of these two molecules have resulted in decreased Tgfb1 production following α-MSH stimulation.
To further clarify the molecular mechanisms related to . Importantly, MITF acts downstream of ERK1/2 and p38 MAPK in melanoma cells 22, 24) . Thus, we focused on MITF as a possible candidate that acts downstream of Mc1r to regulate Tgfb1 production. First, we utilized luciferase reporter assay to evaluate the role of MITF in the regulation of TGF-β1 promoter. In this assay, we found that luciferase activity of TGF-β1 promoter reporter was significantly enhanced when co-transfected with MITF expression plasmid in a dose-dependent manner (Fig. 3B) , indicating the involvement of MITF in regulation of TGF-β1
promoter.
Next, to examine if Mitf is involved in the enhancement of Using these two shRNAs, we found that shRNA#1 was more effective to knockdown Mitf than shRNA#2 (Fig. 3C ).
Proliferation of B16 cells was not affected after knockdown of Mitf (Fig. 3D) . We next examined if Tgfb1 production was affected in these two cell lines by knockdown of Mitf 
4)Effect of Mc1r knockdown on B16 melanoma growth in vivo
Accumulating evidence has unveiled the fundamental roles of TGF-β1 in multiple aspects of cancer progression, including melanoma [25] [26] . In this study, we have identified a Comparing to control group, we found that tumor growth was delayed in mice inoculated with B16 cells knocked down for Mc1r (Fig. 4) . Collectively, these data indicate the importance of α-MSH-MC1R-MITF axis in the regulation of Tgfb1 production in B16 cells, which consequently has an impact on tumor progression in vivo.
5)α-MSH stimulation enhances TGF-β1 expression in human melanoma cells
Finally, we asked whether TGF-β1 expression is enhanced in human melanoma cells following α-MSH stimulation similar to B16 cells. To do so, we first evaluated MC1R expression in human Ak1, C8161 and A375M melanoma cell lines. We found that MC1R is expressed in these cell lines with some variations (Fig. 5A) . Importantly, α-MSH stimulation was effective to enhance TGF-β1 expression ( Fig. 5B and 5C ), and more interestingly this enhancement was correlated to MC1R expression, since melanoma cells with higher expression of MC1R such as A375M showed remarkable enhancement in TGF-β1 expression following α-MSH stimulation (Fig. 5C ). Thus, these data suggest that α-MSH-MC1R axis can also contribute to TGF-β1 production in human melanoma cells.
Discussion
In this study, we demonstrated a novel role for MC1R-mediated signal pathway in the regulation of TGF-β1 production in melanoma cells. TGF-β1, a multifunctional cytokine that play important roles in different aspects of the cellular function, is normally expressed in various tissues, and highly expressed in various cancer cell lines [27] [28] . Importantly, clinical data showed that the serum levels of TGF-β1 in melanoma patients are higher compared with healthy donors 29) , suggesting that TGF-β1 is correlated with melanoma progression in these patients.
MC1R, a cell surface endocytic receptor expressed on melanocytes, was also found to be highly expressed in transformed melanocytes 3, 4, 30) . From these backgrounds, we hypothesized that MC1R-meidated signaling pathway might be related to TGF-β1 production in melanoma By unveiling the involvement of this axis in TGF-β1 production, this report provides an additional evidence of the importance of this pathway in melanogenesis.
Our data showed that the activities of TGF-β1 promoter was correlated with MITF expression levels. In melanoma,
MITF is the target of MAPK pathway at various levels including its transcription and its protein turnover and function 15, 20, 21) , which is essential for melanocyte differentiation 25) , and importantly related to malignant progression 31) .
Based on our in vitro results, we also examined if targeting of α-MSH-MC1R-MITF axis may affect tumor growth in vivo.
We found that tumor growth was delayed in mice inoculated with melanoma cells knocked-down for MC1R compared to wild type control. 
